hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06288906, orgStudyIdInfo id: ASTER Study, briefTitle: Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems, acronym: ASTER, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-30, primaryCompletionDateStruct date: 2027-03, completionDateStruct date: 2027-12, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: IRCCS San Raffaele, class: OTHER, descriptionModule briefSummary: This is a physician-initiated, observational, monocentric, retrospective and prospective Study. The study is intended to assess the feasibility of mechanical thrombectomy of caval and iliofemoral veins according to normal clinical practice in adult patients with symptomatic acute or subacute ileofemoral or caval deep vein thrombosis objectively diagnosed with CT scan imaging., conditionsModule conditions: Thrombosis, Venous, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: mechanical thrombectomy of caval and iliofemoral veins, outcomesModule primaryOutcomes measure: Rate of Technical success, primaryOutcomes measure: Number of Participants presenting Bleeding, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: San Raffaele Hospital, city: Milano, zip: 20132, country: Italy, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06288893, orgStudyIdInfo id: DEU-2001, briefTitle: SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2025-01-01, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: JKT Biopharma Co., Ltd., class: INDUSTRY, descriptionModule briefSummary: Randomized, double-blind, placebo-controlled, multicenter phase II clinical study of SHEN211 tablets, conditionsModule conditions: COVID-19, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized 2:1 to experimental and placebo arms, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, maskingDescription: double-blind, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: SHEN211 Tablets, interventions name: Placebo for SHEN211 Tablets, outcomesModule primaryOutcomes measure: Change from baseline in SARS-CoV-2 viral load at each time point, secondaryOutcomes measure: Time of recovery, secondaryOutcomes measure: Time to response, secondaryOutcomes measure: Time to negative, secondaryOutcomes measure: Percentage of subjects with disappearance of clinical symptoms, secondaryOutcomes measure: Change in COVID-19 symptom score, secondaryOutcomes measure: Ct value change from baseline, secondaryOutcomes measure: Change from baseline in chest CT scan (optional), secondaryOutcomes measure: Percentage of Subjects Progressed, secondaryOutcomes measure: Percent of Subjects Who Died, secondaryOutcomes measure: Safety Assessment Results, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Shenzhen Third People 's Hospital, city: Shenzhen, state: Guangdong, zip: 518112, country: China, contacts name: Hongzhou Lu, ph.D, role: CONTACT, phone: 0755-61232898, email: luhongzhou@fudan.edu.cn, contacts name: Ximin Meng, role: CONTACT, phone: 0755-61222333, phoneExt: 16565, email: szywjd2015@163.com, contacts name: Hongzhou Lu, ph.D, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 22.54554, lon: 114.0683, hasResults: False
protocolSection identificationModule nctId: NCT06288880, orgStudyIdInfo id: kilis_4, briefTitle: Impact of Earthquake Trauma on Nurses' Compassion Fatigue: A Study From Kahramanmaraş, Turkey, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-04-01, completionDateStruct date: 2024-05-01, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: Kilis 7 Aralik University, class: OTHER, collaborators name: Hasan Kalyoncu University, descriptionModule briefSummary: This study investigates the impact of earthquake trauma on compassion fatigue among nurses working in emergency services following the devastating earthquakes on 6 February 2023, in Kahramanmaraş, Turkey. These earthquakes, with magnitudes of approximately 7.7 and 7.6, affected 11 provinces and resulted in over 50,000 deaths and 100,000 injuries, placing emergency service nurses at the forefront of dealing with the aftermath and trauma. The concept of compassion fatigue, characterised by a reduced capacity for empathy after repeated exposure to traumatic events, is a significant concern for nurses who have been directly involved in the care of earthquake victims. This study aims to explore the extent of earthquake trauma and compassion fatigue among these nurses, examining the relationship between these two conditions and their long-term effects. Given the limited research on post-traumatic stress disorder and compassion fatigue among emergency service nurses, this study seeks to contribute valuable insights into the psychological impacts of disaster response on healthcare professionals. The hypotheses tested aim to better understand the risks and psychological burdens faced by nurses in the wake of such natural disasters., conditionsModule conditions: Earthquake, conditions: Compassion Fatigue, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 250, type: ESTIMATED, outcomesModule primaryOutcomes measure: Section 1: Demographic Information Form, primaryOutcomes measure: Section 2: Post-Earthquake Trauma Level Determination Scale, primaryOutcomes measure: Section 3: Compassion Fatigue Short Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Islam Elagöz, city: Kilis, zip: 79100, country: Turkey, contacts name: islam elagöz, role: CONTACT, contacts name: Aynur koyuncu, role: CONTACT, geoPoint lat: 36.71611, lon: 37.115, hasResults: False
protocolSection identificationModule nctId: NCT06288867, orgStudyIdInfo id: FMASU MD28/2024, briefTitle: A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-09-01, completionDateStruct date: 2025-12-01, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-18, sponsorCollaboratorsModule leadSponsor name: Ain Shams University, class: OTHER, descriptionModule briefSummary: This study aims to address hip labral tears and compare between arthroscopic labral repair versus debridement., conditionsModule conditions: Hip Injuries, conditions: Acetabular Labral Tear, conditions: Femoro Acetabular Impingement, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Arthroscopic Labral Repair, interventions name: Arthroscopic Labral Debridement, outcomesModule primaryOutcomes measure: Change from baseline in Hip Function, as measured by Hip Outcome Score (HOS), primaryOutcomes measure: Change from baseline in Hip Function, as measured by Harris Hip Score (HHS), primaryOutcomes measure: Change from baseline in Pain, as measured by the Visual Analogue Scale (VAS), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Ain Shams University, city: Cairo, country: Egypt, contacts name: Karim A Salem, MD, role: CONTACT, phone: 1000017388, phoneExt: +20, email: karimatefsalem@gmail.com, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06288854, orgStudyIdInfo id: 66222, briefTitle: Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer With Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-03, primaryCompletionDateStruct date: 2025-03-31, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Rajavithi Hospital, class: OTHER_GOV, descriptionModule briefSummary: * Efficacy of olanzapine on weight gain in advanced stage gynecologic cancer* Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo, conditionsModule conditions: Weight Gain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: olanzapine vs placebo, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 48, type: ESTIMATED, armsInterventionsModule interventions name: weight gain each group, outcomesModule primaryOutcomes measure: Efficacy of olanzapine on weight gain in advanzed stage gynecologic cancer recieving paclitexal and carboplatin chemotherapy, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06288815, orgStudyIdInfo id: TUH oral fluid TKA, briefTitle: Oral Fluid vs IV Fluid After Primary TKA, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-10, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Thammasat University Hospital, class: OTHER, descriptionModule briefSummary: The goal of this study is to compared efficacy of oral fluid and intravenous fluid after primary unilateral total knee arthroplasty.The main question it aims to answer is:Does oral fluid replacement after primary unilateral total knee arthroplasty provide a patient recover faster than intravenous fluids replacement?, conditionsModule conditions: Osteoarthritis, Knee, conditions: Total Knee Arthroplasty, conditions: Oral Fluid Replacement, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 130, type: ESTIMATED, armsInterventionsModule interventions name: Oral fluid, interventions name: IV fluid, outcomesModule primaryOutcomes measure: Time to stand and walk, secondaryOutcomes measure: Time up and go, secondaryOutcomes measure: Incidence of oliguria, secondaryOutcomes measure: Incidence of nausea/vomiting, secondaryOutcomes measure: Urine specific gravity, secondaryOutcomes measure: the levels of certain electrolytes, secondaryOutcomes measure: the levels of creatinine, secondaryOutcomes measure: the levels of blood urea nitrogen (BUN)., secondaryOutcomes measure: Complications, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 85 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Thammasat University, status: RECRUITING, city: Khlong Luang, state: Pathum Thani, zip: 12120, country: Thailand, contacts name: Yot Tanariyakul, M.D., role: CONTACT, phone: 663930257, email: y.tanariyakul@gmail.com, contacts name: Nattapol Tammachote, M.D., role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 14.06467, lon: 100.64578, hasResults: False
protocolSection identificationModule nctId: NCT06288802, orgStudyIdInfo id: 04-2023-200647, briefTitle: Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital, statusModule overallStatus: RECRUITING, startDateStruct date: 2020-06-15, primaryCompletionDateStruct date: 2024-06, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: South Egypt Cancer Institute, class: OTHER, collaborators name: Shefa Al-orman Children Cancer Hospital, collaborators name: Assiut University, descriptionModule briefSummary: The goal of this cross sectional observational study is to determine the percentage of Wilms tumors among pediatric cancers at Shefa Al-Orman Children Cancer Hospital from june 2020 to june 2024,to study the outcome of patients with Wilms tumor treated according to SIOP Umbrella protocol during the study period and to study the treatment related complications during therapy according to common terminology criteria of adverse events version 5.0 (CTCAE Version 5.0)., conditionsModule conditions: Wilms Tumor, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 50, type: ESTIMATED, outcomesModule primaryOutcomes measure: Overall-survival (OS), secondaryOutcomes measure: Event-free survival (EFS), eligibilityModule sex: ALL, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Shefa Al-orman Children Cancer Hospital, status: RECRUITING, city: Luxor, country: Egypt, contacts name: Mahmoud Elzembely, MD, role: CONTACT, phone: +201146703107, email: elzimbily@aun.edu.eg, geoPoint lat: 25.69893, lon: 32.6421, hasResults: False
protocolSection identificationModule nctId: NCT06288789, orgStudyIdInfo id: SFI-TR, briefTitle: Turkish Validity and Reliability of the Social Frailty Index, statusModule overallStatus: COMPLETED, startDateStruct date: 2024-02-25, primaryCompletionDateStruct date: 2024-03-20, completionDateStruct date: 2024-03-30, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: Pamukkale University, class: OTHER, descriptionModule briefSummary: The aim was to examine the validity and reliability of the Social Frailty Index in Turkish among older adults. 65 years and above older adults will be included included in the study. Older adults who agree to participate in the study will first be administered the Hodkinson Mental Test. Those who score 6 points and above will be included in the study. To evaluate the validity of the \&#34;Social Frailty Index\&#34;, Social Inclusion Scale, Older people\&#39;s quality of life-brief (OPQOL-brief) and Lubben Social Network Scale will be applied to the participants. To determine the reliability of the \&#34;Social Frailty Index\&#34;, older adults who do not receive any treatment will be tested and re-tested at one-week intervals., conditionsModule conditions: Elderly, conditions: Frailty, conditions: Quality of Life, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 186, type: ACTUAL, armsInterventionsModule interventions name: Social Frailty Index, outcomesModule primaryOutcomes measure: Social Frailty Index, secondaryOutcomes measure: Socıal Inclusıon Scale, secondaryOutcomes measure: Older people's quality of life-brief (OPQOL-brief), secondaryOutcomes measure: Lubben Social Network Scale, eligibilityModule sex: ALL, minimumAge: 65 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Elif Gur Kabul, city: Usak, state: Merkez, zip: 64200, country: Turkey, geoPoint lat: 38.67351, lon: 29.4058, hasResults: False
protocolSection identificationModule nctId: NCT06288776, orgStudyIdInfo id: SOD/ERB/2023/22-04, briefTitle: Efficacy of Azadirachta Indica Based Herbal Mouthwash in Treating the Tooth Hypersensitivity, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-02-01, primaryCompletionDateStruct date: 2023-04-30, completionDateStruct date: 2023-04-30, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: Pakistan Institute of Medical Sciences, class: OTHER_GOV, descriptionModule briefSummary: Type of study: Single-blinded clinical trial to evaluate the effectiveness of Azadirachta indica based Herbal mouthwash to treat the tooth sensitivity in patients.Participants aged 20 years and above having Gingival Index score 3 will be included in the study. Their tooth sensitivity will be checked initially and then they will be given Herbal based mouthwash for 3 months. Again, their tooth sensitivity shall be checked after 3 months., conditionsModule conditions: Tooth Sensitivity, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: In this study, participants will be selected by consecutive non-random sampling technique., primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: Single-blinded study where participant will be masked., enrollmentInfo count: 120, type: ACTUAL, armsInterventionsModule interventions name: Herbal based mouthwash, outcomesModule primaryOutcomes measure: Toothsensitivity declination with herbal based mouthwash, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Afsheen Mansoor, city: Islamabad, zip: 44080, country: Pakistan, geoPoint lat: 33.72148, lon: 73.04329, hasResults: False
protocolSection identificationModule nctId: NCT06288750, orgStudyIdInfo id: sdllycyyqx001, briefTitle: Protective Effect of Indocyanine Green Fluorescence Imaging Technology on Parathyroid Glands During Total Thyroidectomy, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-05, sponsorCollaboratorsModule leadSponsor name: Shandong Linglong Yingcheng Hospital, class: NETWORK, descriptionModule briefSummary: Accurate identification and evaluation of the parathyroid glands (PGs) intraoperatively is critical to reduce the incidence of postoperative hypoparathyroidism after total thyroidectomy. Near-infrared fluorescence imaging (NIFI), including the autofluorescence (AF) and indocyanine green fluorescence (ICGF) imaging, is a promising technique to protect PGs. This study aimed to assess whether the combined use of AF and ICGF could reduce the incidence of postoperative hypoparathyroidism and improve the identification and evaluation of PGs during total thyroidectomy., conditionsModule conditions: Total Thyroidectomy, conditions: Parathyroid Function Low Adverse Event, conditions: Parathyroid Glands--Diseases, conditions: Indocyanine Green, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: PREVENTION, maskingInfo masking: DOUBLE, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: Indocyanine Green, interventions name: No indocyanine green, outcomesModule primaryOutcomes measure: Identification of parathyroid glands (PGs) by NIR/ICG camera detected high-contrast, secondaryOutcomes measure: Central lymph node dissetion (CLND), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Shandong Linglong Yingcheng Hospital, status: RECRUITING, city: Yantai, state: Shandong, zip: 264000, country: China, contacts name: Xuan Qiu, MD, role: CONTACT, phone: 8618354280081, email: qiuxuan100@163.com, contacts name: Ni Wang, MD, role: CONTACT, phone: 8618705353551, email: wangni1989@163.com, geoPoint lat: 37.47649, lon: 121.44081, hasResults: False
protocolSection identificationModule nctId: NCT06288737, orgStudyIdInfo id: 54335073, briefTitle: Assessing Patient Engagement in Keratoconus Clinical Research, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2025-03, primaryCompletionDateStruct date: 2026-03, completionDateStruct date: 2027-03, studyFirstPostDateStruct date: 2024-03-01, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: Power Life Sciences Inc., class: INDUSTRY, descriptionModule briefSummary: This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in keratoconus clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.In essence, this trial aims to deepen understanding of the factors influencing participation in keratoconus clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition., conditionsModule conditions: Keratoconus, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CROSSOVER, timePerspective: PROSPECTIVE, enrollmentInfo count: 500, type: ESTIMATED, outcomesModule primaryOutcomes measure: Rate of patients who decide to join in a keratoconus clinical trial, primaryOutcomes measure: Number of keratoconus patients who remain in clinical trial until completion, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Power Life Sciences, city: San Francisco, state: California, zip: 94107, country: United States, contacts name: Michael B Gill, role: CONTACT, phone: 415-900-4227, email: https://www.withpower.com/contact-us@withpower.com, geoPoint lat: 37.77493, lon: -122.41942, documentSection largeDocumentModule largeDocs typeAbbrev: ICF, hasProtocol: False, hasSap: False, hasIcf: True, label: Informed Consent Form, date: 2024-02-23, uploadDate: 2024-02-23T11:13, filename: ICF_000.pdf, size: 73995, hasResults: False